StockData
LivaNova PLC logo

LivaNova PLC (LIVN) stock

LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3021% above fair value
$94.54+2.62 (+2.85%)

Close on Nov 18, 2026Market cap $5.21BP/E 27.9Yield –

Earnings

LivaNova's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 24, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$393.10M
+9.9% on a year earlier
adjusted diluted earnings per share, Q3 FY2026
$1.23
$1.11 a year earlier
Latest guidance
Issued
Nov 4, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of LivaNova's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 24, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 4, 2026before the open$393.10M+9.9%$0.11$1.23Release
Q2 FY2026ended Jun 30, 2026Aug 5, 2026before the open$390.60M+10.8%$1.93$1.26Release
Q1 FY2026ended Mar 31, 2026May 6, 2026before the open$362.30M+14.3%$0.40$0.98Release
Q4 FY2025ended Dec 31, 2025Feb 25, 2026before the open$360.90M+12.2%$0.56$0.86Release
Q3 FY2025ended Sep 30, 2025Nov 5, 2025before the open$357.80M+12.5%$0.49$1.11Release
Q2 FY2025ended Jun 30, 2025Aug 6, 2025before the open$352.50M+10.6%$0.50$1.05Release
Q1 FY2025ended Mar 31, 2025May 7, 2025before the open$316.90M+7.5%-$6.01$0.88Release
Q4 FY2024ended Dec 31, 2024Feb 25, 2025before the open$321.80M+3.8%$1.02$0.81Release
Q3 FY2024ended Sep 30, 2024Oct 30, 2024before the open$318.10M+11.2%$0.60$0.90Release
Q2 FY2024ended Jun 30, 2024Jul 31, 2024before the open$318.60M+8.4%$0.30$0.93Release
Q1 FY2024ended Mar 31, 2024May 1, 2024before the open$294.90M+12.0%-$0.78$0.73Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

LivaNova's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
revenuenon-GAAPFY2026+9% – +10%–NewNov 4, 2026
revenuenon-GAAPFY2026+8% – +9%+7% – +8%RaisedAug 5, 2026
Adjusted diluted earnings per sharenon-GAAPFY2026$4.40 – $4.50–NewNov 4, 2026
Adjusted diluted earnings per sharenon-GAAPFY2026$4.30 – $4.40$4.20 – $4.30RaisedAug 5, 2026
adjusted free cash flownon-GAAPFY2026$140.00M – $160.00M–NewNov 4, 2026
adjusted free cash flownon-GAAPFY2026$140.00M – $160.00M$160.00M – $180.00MLoweredAug 5, 2026

Guidance vs results

The last range LivaNova gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Adjusted diluted earnings per share$3.80 – $3.90$3.90Σ4QWithin range
FY2025Revenue growth+8.5% – +9.5%+10.75%Σ4QAbove range

Guidance history

Every forecast LivaNova put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 4, 2026Adjusted diluted earnings per shareFY2026$4.40 – $4.50New
Nov 4, 2026adjusted free cash flowFY2026$140.00M – $160.00MNew
Nov 4, 2026revenueFY2026+9% – +10%New
Aug 5, 2026Adjusted diluted earnings per shareFY2026$4.30 – $4.40Raised
Aug 5, 2026adjusted free cash flowFY2026$140.00M – $160.00MLowered
Aug 5, 2026revenueFY2026+8% – +9%Raised
May 6, 2026Adjusted diluted earnings per shareFY2026$4.20 – $4.30Raised
May 6, 2026adjusted free cash flowFY2026$160.00M – $180.00MReaffirmed
May 6, 2026revenue growthFY2026+7% – +8%Raised
Feb 25, 2026Adjusted diluted earnings per shareFY2026$4.15 – $4.25New
Feb 25, 2026adjusted free cash flowFY2026$160.00M – $180.00MNew
Feb 25, 2026revenue to growFY2026+6% – +7%New
Nov 5, 2025Adjusted diluted earnings per shareFY2025$3.80 – $3.90New
Nov 5, 2025adjusted free cash flowFY2025$160.00M – $180.00MNew
Nov 5, 2025revenue to growFY2025+8.5% – +9.5%New
Nov 5, 2025organic revenueFY2025+9.5% – +10.5%Raised
Aug 6, 2025Adjusted diluted earnings per shareFY2025$3.70 – $3.80Raised
Aug 6, 2025adjusted free cash flowFY2025$140.00M – $160.00MRaised
Aug 6, 2025revenue growth ... on a constant-currency basisFY2025+8% – +9%Raised
Aug 6, 2025revenue ... on an organic basisFY2025+9% – +10%Raised

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases LivaNova filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Results
  7. Results
  8. Results
  9. Results
  10. Results
  11. Results
  12. Results
  13. Update
  14. Update
  15. Results

See a number that looks wrong?